Challenges and Stategies of Globalization in Emerging Economies: A Case Study of Pfizer

References

[1] Access to Medicine Foundation. (2025). Pfizer Inc - Access to Medicine Foundation. https://accesstomedicinefoundation.org/company/pfizer

[2] Acheampong, A. O., Boateng, E., Amponsah, M., & Dzator, J. (2021). Revisiting the economic growth–energy consumption nexus: does globalisation matter? Energy Economics, 102, 105472.

[3] Adidas Group. (2020). Annual Report 2020. https://www.adidasgroup.com/media/filer_public/c4/8d/c48d8ed7-f97c-45bc-b7d5-8841e6d6f077/2020_gb_en.pdf

[4] Ahmed, Z., Ahmad, M., Rjoub, H., Kalugina, O. A., & Hussain, N. (2022). Economic growth, renewable energy consumption, and ecological footprint: Exploring the role of environmental regulations and democracy in sustainable development. Sustainable Development, 30(4), 595–605.

[5] Ahmed, Z., Zhang, B., & Cary, M. (2021). Linking economic globalisation, economic growth, financial development, and ecological footprint: Evidence from symmetric and asymmetric ARDL. Ecological Indicators, 121, 107060.

[6] Ahunwan, B. (2021). Globalisation and Corporate Governance in Developing Countries: Micro Analysis of Global Corporate Interconnection between Developing African Countries and Developed Countries. BRILL.

[7] Anderson, R., & Patel, S. (2020). Dynamic pricing strategies in pharmaceutical markets: The role of AI. Journal of Market Analytics, 12(4), 45–58.

[8] Baloch, M. A., Ozturk, I., Bekun, F. V., & Khan, D. (2021). Modeling the dynamic linkage between financial development, energy innovation, and environmental quality: does globalisation matter? Business Strategy and the Environment, 30(1), 176–184. https://doi.org/10.1002/bse.2615

[9] BBC News. (2014, May 13). Pfizer: The making of a global drugs giant. https://www.bbc.com/news/business-27309851

[10] Braylyan, B. (2024). Revolutionizing healthcare: Pfizer’s AI journey to drug discovery and personalized medicine. Virtasant.

[11] Brown, T., Smith, J., & Davis, P. (2021). AI applications in pharmaceutical patent management. International Journal of Drug Policy, 35(3), 78–92.

[12] Chauhan, V., Rai, V., & Singh, S. (2024). The Globalization of the Pharmaceutical Industry: Trends and Implications. IASR Journal of Medical and Pharmaceutical Sciences, 4(4), 199–203.

[13] Chen, L. (2021). Economic forecasting with AI: Implications for global pharmaceutical companies. AI in Business Review, 9(2), 34–50.

[14] EBSCO. (2025, March 18). Pfizer. EBSCO Research Starters. https://www.ebsco.com/research-starters/business-and-management/pfizer

[15] Encyclopædia Britannica. (2025). Pfizer Inc. | Pharmaceuticals, Vaccines & Company History. https://www.britannica.com/money/Pfizer-Inc

[16] Fadare, J. O., et al. (2023). Globalization of the pharmaceutical industry: Trends and challenges. International Journal of Pharmaceutical Sciences and Research, 14(3), 1201–1212. https://doi.org/10.13040/IJPSR.0975-8232.14(3).1201-12

[17] Furr, N., Ozcan, P., & Eisenhardt, K. M. (2022). What is digital transformation? Core tensions facing established companies on the global stage. Global Strategy Journal, 12(4), 595–618.

[18] Fonseca, L. (2024). Pfizer's AI-driven healthcare transformation with AWS. Amazon Web Services.

[19] GlobalData. (2025). Pfizer Inc Company Profile. https://www.globaldata.com/store/report/pfizer-inc-company-profile/

[20] Gopinath, G., Pierre-Olivier, G., Andrea, F. P., & Petia, T. (2024). Changing Global Linkages: A New Cold War? IMF Working Paper 2024-076. International Monetary Fund.

[21] Goybo. (2024). How Pfizer's research and development drives market leadership. Goybo.

[22] Grimm, M., Schuette, M., Lockard, T., Boudreau, C., & Goff, K. (2023). Strategic audit report: Pfizer – Brand-name pharmaceutical manufacturing (U.S.) [Honors thesis, University of Nebraska-Lincoln]. https://digitalcommons.unl.edu/honorstheses/611

[23] Haine, P. P. (2023). Relative valuation of Pfizer Inc. [Thematic paper, Mahidol University].

[24] History Oasis. (2024, January 1). History & Timeline of Pfizer. https://www.historyoasis.com/tags/pfizer

[25] Iancu, E. M., & Kandalaft, L. E. (2020). Challenges and advantages of cell therapy manufacturing under Good Manufacturing Practices. Current Opinion in Biotechnology, 65, 233–241.

[26] Ibn-Mohammed, T., et al. (2021). A critical analysis of the impacts of COVID-19 on the global economy and ecosystems. Resources, Conservation and Recycling, 164, 105169. https://doi.org/10.1016/j.resconrec.2020.105169

[27] International Monetary Fund. (2023). World Economic Outlook: Navigating Global Differences. https://www.imf.org/en/Publications/WEO

[28] ISPE. (2021). Pharma 4.0. https://ispe.org/initiatives/pharma-4.0

[29] ISPE. (2021a). Pharma 4.0: Hype or Reality. https://ispe.org/pharmaceutical-engineering

[30] Jahanger, A., Usman, M., & Balsalobre-Lorente, D. (2022). Autocracy, democracy, globalisation, and environmental pollution. Journal of Public Affairs, 22(4), e2753. https://doi.org/10.1002/pa.2753

[31] Jahanger, A., Usman, M., Murshed, M., Mahmood, H., & Balsalobre-Lorente, D. (2022). The linkages between natural resources, human capital, globalisation, economic growth, financial development, and ecological footprint: The moderating role of technological innovations. Resources Policy, 76, 102569. https://doi.org/10.1016/j.resourpol.2022.102569

[32] Johnson, M., & Lee, K. (2022). AI in vaccine development: Lessons from the COVID-19 pandemic. Vaccine Research Journal, 15(1), 12–25.

[33] Kluth, A. (2024). The US Can’t Be Protectionist and World Leader. Bloomberg. https://www.bloomberg.com/opinion/articles/2024-05-29/the-us-can-t-be-protectionist-and-world-leader

[34] Khaustovich, V. (2022, June). Brand Name Pharmaceutical Manufacturing in the US: Industry Report 32541A. IBISWorld. https://my-ibisworld.com.libproxy.unl.edu/us/en/industry/32541a/about

[35] Kihombo, S., Vaseer, A. I., Ahmed, Z., Chen, S., Kirikkaleli, D., & Adebayo, T. S. (2022). Is there a tradeoff between financial globalisation, economic growth, and environmental sustainability? Environmental Science and Pollution Research, 29, 3983–3993. https://doi.org/10.1007/s11356-021-15878-z

[36] Kozhyna, A., Razina, T., Kravchenko, A., Kuprii, T., & Melnyk, T. (2022). Human capital development in the context of globalization processes: Regulatory aspect. Economic Affairs, 67(4), 887–895. https://doi.org/10.46852/0424-2513.4s.2022.22

[37] Kulkarni, G. R., Agrahari, S., & Sen, S. (2023). Launching a new brand in the multi-brand portfolio: Evaluating the mediating role of detailing priority and time on physicians’ prescription behaviour. International Journal of Pharmaceutical and Healthcare Marketing.

[38] Meshcheriakov, A., Bodenchuk, L., Liganenko, I., Rybak, O., & Lobunets, T. (2023). Trends in the development of the banking system of Ukraine under conditions of military actions and globalization influences. Financial and Credit Activity: Problems of Theory and Practice, 3(50), 8–22. https://doi.org/10.55643/fcaptp.3.50.2023.3993

[39] Murshed, M., Apergis, N., Alam, M. S., Khan, U., & Mahmud, S. (2022). The impacts of renewable energy, financial inclusivity, globalisation, economic growth, and urbanisation on carbon productivity. Renewable Energy, 196, 824–838. https://doi.org/10.1016/j.renene.2022.07.012

[40] Nahavandi, S. (2019). Industry 5.0—A human-centric solution. Sustainability, 11, 4371.

[41] Nguyen, H., Taylor, R., & White, G. (2022). Cultural adaptation in global healthcare marketing using AI tools. Marketing Science Quarterly, 14(5), 67–80.

[42] Norouzi, N. (2021). Post-COVID-19 and globalisation of oil and natural gas trade. International Journal of Energy Research, 45(10), 14338–14356. https://doi.org/10.1002/er.6762

[43] Papathanasiou, M. M., & Kontoravdi, C. (2020). Engineering challenges in therapeutic protein product and process design. Current Opinion in Chemical Engineering, 27, 81–88.

[44] PitchGrade. (2024). Pfizer: AI use cases. PitchGrade.

[45] Pfizer. (2025a). About Pfizer. https://www.pfizer.com/about/careers/en-ir/about-pfizer

[46] Pfizer. (2025b). Pfizer Company Fact Sheet | Key Pharma & Consumer Health. https://www.pfizer.com/news/media-resources/press-kits/corporate-media-kit

[47] Pfizer. (2025c). History. https://www.pfizer.com/about/history

[48] PharmaLeaders. (2024). Pfizer leads the way for AI-powered compliance copilots. PharmaLeaders.

[49] Potwora, M., Zakryzhevska, I., Mostova, A., Kyrkovskyi, V., & Saienko, V. (2023). Marketing strategies in e-commerce: personalised content and recommendations. Financial and Credit Activity: Problems of Theory and Practice, 5(52), 562–573. https://doi.org/10.55643/fcaptp.5.52.2023.4190

[50] Saif, M., Maury, S., Yadav, D., Wasiullah, M., & Yadav, P. (2024). Global marketing strategies for pharmaceutical companies. International Journal of Pharmaceutical Science Invention, 13(3), 42–44. https://doi.org/10.35629/6718-13034244

[51] Sarkis, M., Bernardi, A., Shah, N., & Papathanasiou, M. M. (2021). Emerging challenges and opportunities in pharmaceutical manufacturing and distribution. Processes, 9, 457. https://doi.org/10.3390/pr9030457

[52] Sarwat, S., Godil, D. I., Ali, L., Ahmad, B., Dinca, G., & Khan, S. A. R. (2022). The role of natural resources, renewable energy, and globalisation in testing EKC theory in BRICS countries. Environmental Science and Pollution Research, 29, 23677–23689. https://doi.org/10.1007/s11356-021-17557-5

[53] Seoane, M. F. V. (2022). Alibaba’s discourse for the digital Silk Road: The electronic World Trade Platform and inclusive globalisation. In China’s Globalizing Internet (pp. 67–82). Routledge.

[54] Setser, B. (2024). The surprising resilience of globalization: An examination of economic fragmentation. Aspen Institute.

[55] Schmidt, H., & Huber, F. (2021). The historical evolution of the pharmaceutical industry: From ancient remedies to modern medicines. Pharmaceutical History Review, 23(1), 15–27.

[56] Sheposh, R. (2025). Pfizer. EBSCO Research Starters.

[57] Shukla, A. A., Wolfe, L. S., Mostafa, S. S., & Norman, C. (2017). Evolving trends in mAb production processes. Bioengineering & Translational Medicine, 2, 58–69.

[58] SIEMENS. (2021). Embracing the digital transformation. https://assets.new.siemens.com

[59] Smith, A. (2023). AI in drug discovery: Transforming pharmaceutical innovation. Journal of Pharmaceutical Sciences, 18(6), 89–102.

[60] Stacciarini, J. H. S. (2024). Research and development in the pharmaceutical sector. Revista Terceiro Incluído, 14(1), 14109. http://dx.doi.org/10.5216/teri.v14i1.79594

[61] Stacciarini, J. H. S. (2024a). The consolidation of the pharmaceutical sector in the global economy. https://doi.org/10.5281/zenodo.10377840

[62] Stacciarini, J. H. S. (2024b). Drug advertising in Brazil. Sociedade & Natureza, 36(1). https://doi.org/10.14393/SN-v36-2024-72114

[63] Stacciarini, J. H. S. (2024c). The global pharmaceutical sector: Numbers and dynamics. https://doi.org/10.5281/zenodo.13891633

[64] Taylor, R. (2020). Competitive intelligence through AI in the pharmaceutical industry. Business Intelligence Quarterly, 10(3), 23–40.

[65] The Economist. (2024). The world’s economic order is breaking down. https://www.economist.com

[66] UNCTAD. (2023). World Investment Report 2023. https://unctad.org/publication/world-investment-report2023

[67] U.S. Department of Justice. (2025, February 5). Justice Department announces largest health care fraud settlement in its history. https://www.justice.gov

[68] Virtasant. (2024). Pfizer's AI drug discovery cuts years off development time. Virtasant.

[69] Verbeke, A., & Hutzschenreuter, T. (2021). The dark side of digital globalisation. Academy of Management Perspectives, 35(4), 606–621. https://doi.org/10.5465/amp.2020.0015

[70] Volkswagen Group. (2022). Annual Report 2021. https://www.volkswagenag.com

[71] Wikipedia. (2025, March 27). Pfizer. https://en.wikipedia.org/wiki/Pfizer

[72] Williams, D., & Carter, J. (2023). Navigating regulatory complexities with AI: A case study of Pfizer. Regulatory Affairs Journal, 20(4), 56–72.

[73] Wu, G. (2023). Exploring the value of AI technology in optimizing supply chain data for pharmaceutical companies. Innovation in Science and Technology, 2(3), 1–4. https://doi.org/10.56397/IST.2023.05.01

[74] Yahoo Finance. (2025). Pfizer Inc. (PFE) Company Profile & Facts. https://finance.yahoo.com/quote/PFE/profile/

@article{1716387,
      author = {Chika Ozo Chime JR},
      title = {Challenges and Stategies of Globalization in Emerging Economies: A Case Study of Pfizer},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {10},
      pages = {1642-1655},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1716387.pdf},
      abstract = {Globalization presents both opportunities and challenges for the pharmaceutical industry, particularly in emerging economies. This study examines Pfizer's strategies for navigating these complexities, focusing on key areas such as digital innovation, patent management, market competition, regulatory compliance, cultural adaptation, and economic volatility. Facing increasing fragmentation and regionalization in global trade, Pfizer leverages digital tools aligned with Pharma 4.0 principles to enhance manufacturing efficiency, supply chain management, and drug development processes. The adoption of technologies like Amazon SageMaker and Bedrock facilitates data-driven decision-making and accelerates innovation, exemplified by the rapid development of its COVID-19 vaccine. Patent expirations pose a significant risk, which Pfizer mitigates through predictive analytics to identify new drug candidates and optimize pricing strategies for off-patent medications. Intense market competition necessitates targeted marketing efforts, employing AI to tailor strategies to diverse consumer needs and cultural preferences. Navigating complex regulatory landscapes is streamlined through AI-powered compliance copilots, ensuring adherence to global standards. Furthermore, Pfizer addresses economic volatility by utilizing AI for demand forecasting and dynamic pricing models to stabilize operations. This analysis highlights the critical role of digital transformation and strategic agility in addressing globalization challenges. Despite deglobalization trends and geopolitical tensions, Pfizer demonstrates resilience through innovative solutions and a commitment to maintaining a robust R&D pipeline. The study underscores the significance of integrating advanced technologies and adaptive strategies for pharmaceutical companies operating in a rapidly evolving global market},
      keywords = {Globalization, Pfizer, Pharmaceutical Industry, Digital Innovation, Patent Management, Market Competition, Regulatory Compliance, Cultural Adaptation, Economic Volatility.},
      month = {April},
      doi = {https://doi.org/10.64388/IREV9I10-1716387}
  }